Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

Autor: Kenemans, P, Bundred, Nj, Foidart, Jm, Kubista, E, von Schoultz, B, Sismondi, Piero, Vassilopoulou Sellin, R, Yip, Ch, Egberts, J, Mol Arts, M, Mulder, R, van Os, S, Beckmann, Mw, Sismondi, P, Beckmann, M, Baum, M, Gray, R, Burger, Cw, van Diest PJ, Harbeck, N, Senn, Hj, Svane, G, Prins, Mh, Davidson, B, Peters, R, Longo, Ml, Kappelle, Lj, Maclennan, Ah, Baber, R, Eden, Ja, Furnival, C, Stuckey, B, Farrell, E, Singer, Cf, Marth, C, Reitsamer, R, Sevelda, P, Salzer, H, Thiel, I, Winter, R, Putyrski, L, Beliakouski, V, Gedrevich, Z, Tjalma, W, Desreux, J, Dhont, M, Depypere, H, van den Broecke, R, L'Hermite, M, Nolens, Jp, Rozenberg, S, Simon, P, Vergote, I, Gaspard, U, Janssens, D, De Gezelle, H, Merchiers, E, Aldrighi, Jm, Badalotti, M, Bagnoli, Vr, Fernandes, Ce, Ferriani, R, Pinto Neto AM, Menke, Ch, Petti, Da, Urbanetz, A, Del Giglio, A, Cunill, E, Sepúlveda, H, Soto, L, Uribe, A, Valdivia, I, Baptista, J, Loaciga, K, Bendova, M, Buchta, K, Pecha, V, Reslova, T, Hlavackova, O, Mikulik, M, Kütner, R, Padrik, P, Puistola, U, Ylikorkala, O, Mäenpää Liukko, K, Brémond, A, Faure, C, Seffert, P, Delozier, T, Espie, M, Dupaigne, D, Hoffet, M, Laffargue, F, Tunon de Lara, C, Largillier, L, Namer, M, Dognon, L, Routiot, T, This, P, Touraine, P, Kimmig, R, Kümmel, S, Weiss, J, Engel, U, Brucker, C, de Waal JC, Mallmann, P, Rühl, I, Untch, M, Neumann, C, Kulp, A, Krause Bergmann, B, Schmidt Rhode, P, Seifert Klauss, V, Wallwiener, D, Nestle Krämling, C, Starfl inger, F, Sohn, C, Bastert, G, Thomas, A, Lichtenegger, W, Höss, C, Chatsiproios, D, Jonat, W, de Wilde, R, Dewitz, T, Kühn, T, Kiesel, L, Blümel, B, Schindler, C, Splitt, G, Leitsmann, H, Köhler, U, Langanke, D, Landthaler, R, Hindenburg, Hj, Schoenegg, W, Conrad, B, Ortmann, O, Boér, K, Boros, J, Cseh, J, Kövér, E, Landherr, L, Ruzsa, A, Erfán, J, Fábián, F, Páli, K, Biglia, Nicoletta, Genazzani, Ar, Mariani, R, Martoni, A, Scambia, G, Santoro, A, Burlizzi, S, Amunni, G, Amadori, D, Noh, Dy, Kim, Jg, Ahn, Sh, Kang, Bm, Noh, Wc, Kim, Mh, Lee, Mh, Lee, Jj, Keire, G, Baltina, D, Nik Nasri, N, Gomez, P, Sivalingam, Muniandy, S, Cardenas, J, Mainero, F, Uscanga, S, Fuentes, A, Lugo, R, Heijmans, H, The, Hs, Franke, H, van Riel, J, van der Vegt, S, Boven, E, Houben, P, Kok, A, van Weering, H, van de Walle, A, Burggraaff, Jm, Alcedo, J, Kornafel, J, Litwiniuk, M, Karnicka, H, Bablok, L, Marianowski, Basta, A, Jakimiuk, A, Curescu, S, Draganescu, Me, Eniu, Ae, Zbranca, E, Peltecu, G, Ancar, V, Smetnik, V, Kullikov, Ep, Petrossian, A, Stekolschikova, O, Popov, A, Zoziouk, N, Krikunova, Li, Semiglazov, V, Konstantinova, M, Bezhenar, Vf, Diatchouk, A, Manikhas, G, Korytova, Ly, Vinogradov, V, Sokurenko, V, Baranov, An, Arkhipovsky, Vl, Bogatova, Ik, Akhmadulina, Li, Kuts, Tn, Susloparova, Sa, Mitashok, I, Kanzalie, Al, Bryuzgin, Vv, Malygin, En, Sergeev, Ie, Pasman, Nm, Akishina, Zv, Tuev, Av, Kopp, M, Soloviev, Vi, Evtushenko, Id, Ershov, Gv, Devyatchenko, Nf, Potapov, Yn, Cheporov, Sv, Ogurtsov, Av, Chrustalev, On, Lazareva, Dg, Bryukhina, E, Matrosova, M, Yu, Sl, Wong, Pc, Masak, L, Sadovsky, O, Petrovicova, Z, Suska, P, De Pablo JL, García, E, Iglesias, J, Mattsson, L, Granberg, G, Berglund, L, Friberg, B, Chen, St, Chow, Sn, Lee, Jn, Wang, Kl, Limpaphayom, Kk, Boonjong, S, Jirapinyo, M, Sakondhavat, C, Taechakraichana, N, Techatraisak, K, Wilawan, K, Tatarchuk, T, Dudar, L, Koshukova, G, Gyryachyy, V, Hotko, Ys, Kostynskyy, Y, Paramonov, V, Pertseva, T, Shparyk, Y, Tarasova, O, Kosey, N, Solskiy, Y, Smolanka, I, Kvashenko, V, Grishyna, O, Dzyak, G, Drew, Jp, Mansel, R, Williamson, J, Kingsland, Cr, Vishwanath, L, Bliss, R, Crawford, D, Winters, Z, Browell, D, Paterson, M, Ind, T, Rostom, A, Pitkin, J.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______970::7bb13c8ee300e3adf24729a7c221c4e4
http://hdl.handle.net/2318/120246

Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial.

Autor: Stebbing J; Division of Cancer, Imperial Centre for Translational and Experimental Medicine, London, UK. j.stebbing@imperial.ac.uk.; Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK. j.stebbing@imperial.ac.uk., Baranau YV; Department of Oncology, Belarusian State Medical University, Minsk, Belarus., Baryash V; Department of Oncology, Belarusian State Medical University, Minsk, Belarus., Manikhas A; City Clinical Oncology Dispensary, Saint Petersburg, Russian Federation., Moiseyenko V; Clinical Research Center of Specialised Types of Care (Oncology), GBUZ Saint Petersburg, Saint Petersburg, Russian Federation., Dzagnidze G; S. Khechinashvili University Clinic, Ltd, Tbilisi, Georgia., Zhavrid E; N.N. Alexandrov National Cancer Centre of Belarus, Minsk Region, Belarus., Boliukh D; Vinnytsya Regional Clinical Oncology Dispensary, Vinnytsia, Ukraine., Pikiel J; Wojewodzkie Centrum Onkologii, Gdańsk, Poland., Eniu AE; Hôpital Riviera-Chablais, Vaud-Valais, Rennaz, Switzerland., Li RK; St Luke's Medical Center, Quezon City, Philippines., Tiangco B; The Medical City, Ortigas Avenue, Pasig City, Philippines., Lee SJ; Celltrion, Inc., Incheon, Republic of Korea., Kim S; Celltrion, Inc., Incheon, Republic of Korea.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Aug; Vol. 188 (3), pp. 631-640. Date of Electronic Publication: 2021 Jun 20.

Efficacy and safety of CT-P6 versus reference trastuzumab in HER2-positive early breast cancer: updated results of a randomised phase 3 trial.

Autor: Esteva FJ; Perlmutter Cancer Center, NYU Langone Health, 160 E 34th Street, New York, 10016, USA.; New York University Langone Medical Center, 550 1st Avenue, New York, 10016, USA., Baranau YV; Department of Oncology, Belarusian State Medical University, 220013, Minsk, Belarus., Baryash V; Department of Oncology, Belarusian State Medical University, 220013, Minsk, Belarus., Manikhas A; City Clinical Oncology Dispensary, Saint Petersburg, 198255, Russian Federation., Moiseyenko V; GBUZ Saint Petersburg Clinical Research Center of Specialised Types of Care (Oncology), Saint Petersburg, 197758, Russian Federation., Dzagnidze G; S. Khechinashvili University Clinic, Ltd, 0177, Tbilisi, Georgia., Zhavrid E; N.N. Alexandrov National Cancer Centre of Belarus, 223040, Minsk Region, Belarus., Boliukh D; Vinnytsya Regional Clinical Oncology Dispensary, Vinnytsia, 21029, Ukraine., Stroyakovskiy D; Moscow City Oncology Hospital, Moscow, 143423, Russian Federation., Pikiel J; Wojewodzkie Centrum Onkologii, 80-219, Gdańsk, Poland., Eniu AE; Cancer Institute 'Ion Chiricuta', 400015, Cluj-Napoca, Romania., Li RK; St. Luke's Medical Center, 1102, Quezon City, Philippines., Rusyn AV; Transcarpathian Regional Clinical Oncology Dispensary, Transcarpathian, 88000, Ukraine., Tiangco B; The Medical City, Ortigas Avenue, Pasig City, Philippines., Lee SJ; CELLTRION, Inc., Incheon, 22014, Republic of Korea., Lee SY; CELLTRION, Inc., Incheon, 22014, Republic of Korea., Yu SY; CELLTRION, Inc., Incheon, 22014, Republic of Korea., Stebbing J; Division of Cancer, Imperial Centre for Translational and Experimental Medicine, Du Cane Road, London, W12 0HS, UK. j.stebbing@imperial.ac.uk.; Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK. j.stebbing@imperial.ac.uk.

Publikováno v: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2019 Oct; Vol. 84 (4), pp. 839-847. Date of Electronic Publication: 2019 Aug 19.

A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer.

Autor: Llombart-Cussac A; Hospital Universitario Arnau Vilanova, Lleida, Spain. allombart@arnau.scs.es, Martin M, Harbeck N, Anghel RM, Eniu AE, Verrill MW, Neven P, De Grève J, Melemed AS, Clark R, Simms L, Kaiser CJ, Ma D

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2007 Jun 15; Vol. 13 (12), pp. 3652-9.